Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.

Thomas, K S; Apfelbacher, C A; Chalmers, J R; Simpson, E; Spuls, P I; Gerbens, L A A; Williams, H C; Schmitt, J; Gabes, M; Howells, L; Stuart, B L; Grinich, E; Pawlitschek, T; Burton, T; Howie, L; Gadkari, A; Eckert, L; Ebata, T; Boers, M; Saeki, H; Nakahara, T; Katoh, N

Thomas, K S; Apfelbacher, C A; Chalmers, J R; Simpson, E; Spuls, P I; Gerbens, L A A; Williams, H C; Schmitt, J; Gabes, M; Howells, L; Stuart, B L; Grinich, E; Pawlitschek, T; Burton, T; Howie, L; Gadkari, A; Eckert, L; Ebata, T; Boers, M; Saeki, H; Nakahara, T; Katoh, N.

Affiliation

Thomas KS; Centre of Evidence Based Dermatology, School of Medicine, Nottingham, UK.
Apfelbacher CA; Institute of Social Medicine and Health Systems Research (ISMHSR), Otto von Guericke University Magdeburg, Magdeburg, Germany.
Chalmers JR; Centre of Evidence Based Dermatology, School of Medicine, Nottingham, UK.
Simpson E; Department of Dermatology, Oregon Health & Science University, Portland, OR, USA.
Spuls PI; Department of Dermatology, Amsterdam Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Gerbens LAA; Department of Dermatology, Amsterdam Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Williams HC; Centre of Evidence Based Dermatology, School of Medicine, Nottingham, UK.
Schmitt J; Center for Evidence-based Healthcare, Medical Faculty Carl Gustav Carus, Dresden, Germany.
Gabes M; Medical Sociology, Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
Howells L; Centre of Evidence Based Dermatology, School of Medicine, Nottingham, UK.
Stuart BL; Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK.
Grinich E; School of Medicine (Department of Dermatology), Oregon Health & Science University, Portland, OR, USA.
Pawlitschek T; School of Medicine (Department of Dermatology), Oregon Health & Science University, Portland, OR, USA.
Burton T; Patient representative (independent), Nottingham, UK.
Howie L; Global Parents for Eczema Research, Brisbane, Australia.
Gadkari A; Health Economics and Outcomes Research, Boehringer Ingelheim Inc., Ingelheim, Rheinland-Pfalz, Germany.
Eckert L; Global Dupixent Business Partner, sanofi GHEVA, 1 av. Pierre Brossolette, Chilly-Mazarin, 91380, France.
Ebata T; Chitofuna Dermatology Clinic, Tokyo, Japan.
Boers M; Department of Epidemiology and Data Science, Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.
Saeki H; Department of Dermatology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, Japan.
Nakahara T; Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Katoh N; Department of Dermatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Br J Dermatol ; 185(1): 139-146, 2021 07.

Article de En | MEDLINE | ID: mdl-33393074

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Eczéma atopique / Eczéma Type d'étude: Guideline / Prognostic_studies / Qualitative_research Aspects: Patient_preference Limites: Adolescent / Adult / Child / Humans / Infant Pays/Région comme sujet: Asia Langue: En Journal: Br J Dermatol Année: 2021 Type de document: Article Pays d'affiliation: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google